CytomX Therapeutics CTMX
NASDAQ CTMX
$2.43 -0.08 (-2.99%)
As of: Oct 21, 2026 · 2:50 PM EDT

CytomX Therapeutics (CTMX) Interest Paid (2015)

Updated

Analysis

CytomX Therapeutics (CTMX) Interest Paid (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn -
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn -
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn -
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn -
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 1.07 Bn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn 1.25 Bn
10 CytomX Therapeutics 533.95 Mn -423.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 61,000.00
Jun 30, 2015 75,000.00
Mar 31, 2015 84,000.00
API Access

CytomX Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CTMX&period=max&api_key=YOUR_API_KEY